GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment

References

• Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.
   PubMed Web of Science ®Google Scholar
• Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007; 4:626–634.
   PubMedGoogle Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley PMA, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23:698–702.
   PubMed Web of Science ®Google Scholar
• Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis 2012; 7:653–661.
   PubMed Web of Science ®Google Scholar
• Tashkin DP. Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications. Curr Opin Pulm Med 2013; 19:116–124.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60:925–931.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2006 revision. Available from: http://www.goldcopd.org (accessed September 1, 2015).
   Google Scholar
• Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: National Clinical Guideline Centre, 2010. Available from: https://www.nice.org.uk/guidance/cg12 (accessed September 1, 2015).
   Google Scholar
• Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health 1970; 21:418–424.
   PubMed Web of Science ®Google Scholar
• Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711–715.
   PubMed Web of Science ®Google Scholar
• Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56:880–887.
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007; 101:146–153.
   PubMed Web of Science ®Google Scholar
• Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011; 12:40.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581–586.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34:648–654.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011 revision. Available from: http://www.goldcopd.org (accessed September 1, 2015).
   Google Scholar
• Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J 2013; 42:647–654.
   PubMed Web of Science ®Google Scholar
• Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW. Implications of the GOLD 2011 Disease Severity Classification in the COPD Gene Cohort. Lancet Respir Med 2013; 1:43–50.
   PubMed Web of Science ®Google Scholar
• Kim S, Oh J, Kim Y, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YC, Lim SC. Differences in classification of COPD group using COPD Assessment Test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med 2013; 13:35.
   PubMed Web of Science ®Google Scholar
• Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis 2014; 9:551–561.
   PubMed Web of Science ®Google Scholar
• Rieger-Reyes C, García-Tirado FJ, Rubio-Galán FJ, Marín-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new Global Initiative for Chronic Obstructive Lung Disease 2011 guidelines: COPD Assessment Test versus modified Medical Research Council scale. Arch Bronconeumol 2014; 50:129–134.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2013 Update. Available from: http://www.goldcopd.org (accessed September 1, 2015).
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van Der Grinten CP, Gustafsson P, Jensen R. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Chhabra SK, Kumar R, Gupta U, Rahman M, Dash DJ. Prediction equations for spirometry in adults from Northern India. Indian J Chest Dis Allied Sci 2014; 56:221–229.
   PubMedGoogle Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174.
   PubMed Web of Science ®Google Scholar
• Rhee CK, Kim JW, Hwang YI, Lee JH, Jung KS, Lee MG, Yoo KH, Lee SH, Shin KC, Yoon HK. Discrepancies between modified Medical Research Council dyspnea score and COPD Assessment Test score in patients with COPD. Int J Chron Obstruct Pulmon Dis 2015; 10:1623–1631.
   PubMed Web of Science ®Google Scholar
• Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Solanes-García I, Agüero R, Feu-Collado N, Calle-Rubio M. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest 2015; 148:159–168.
   PubMed Web of Science ®Google Scholar